AVANIR Pharmaceuticals (NASDAQ:AVNR)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Recs

3
Player Avatar maine2012 (< 20) Submitted: 8/25/2006 2:18:27 PM : Underperform Start Price: $7.41 AVNR Score: +107.44

I FOOLISHLY choose this stock and based on a crazy madman and have watched it plummet ever since.

Featured Broker Partners


Advertisement